SI1578949T1 - Usmerjena vključitev keto aminokislin v proteine - Google Patents
Usmerjena vključitev keto aminokislin v proteineInfo
- Publication number
- SI1578949T1 SI1578949T1 SI200331612T SI200331612T SI1578949T1 SI 1578949 T1 SI1578949 T1 SI 1578949T1 SI 200331612 T SI200331612 T SI 200331612T SI 200331612 T SI200331612 T SI 200331612T SI 1578949 T1 SI1578949 T1 SI 1578949T1
- Authority
- SI
- Slovenia
- Prior art keywords
- amino acids
- proteins
- keto amino
- site specific
- orthogonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41926502P | 2002-10-16 | 2002-10-16 | |
US42099002P | 2002-10-23 | 2002-10-23 | |
PCT/US2003/032576 WO2004035743A2 (en) | 2002-10-16 | 2003-10-15 | Site specific incorporation of keto amino acids into proteins |
EP03809019A EP1578949B1 (en) | 2002-10-16 | 2003-10-15 | Site specific incorporation of keto amino acids into proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1578949T1 true SI1578949T1 (sl) | 2009-08-31 |
Family
ID=32110229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200331612T SI1578949T1 (sl) | 2002-10-16 | 2003-10-15 | Usmerjena vključitev keto aminokislin v proteine |
Country Status (17)
Country | Link |
---|---|
US (5) | US7432092B2 (sl) |
EP (2) | EP1578949B1 (sl) |
JP (1) | JP4444113B2 (sl) |
KR (1) | KR20050072441A (sl) |
AT (2) | ATE526414T1 (sl) |
AU (2) | AU2003277373B2 (sl) |
CA (1) | CA2502029C (sl) |
CY (1) | CY1110483T1 (sl) |
DE (1) | DE60327369D1 (sl) |
DK (1) | DK1578949T3 (sl) |
ES (1) | ES2324608T3 (sl) |
HK (1) | HK1083351A1 (sl) |
IL (3) | IL167715A (sl) |
MX (1) | MXPA05003983A (sl) |
PT (1) | PT1578949E (sl) |
SI (1) | SI1578949T1 (sl) |
WO (1) | WO2004035743A2 (sl) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002085923A2 (en) * | 2001-04-19 | 2002-10-31 | The Scripps Research Institute | In vivo incorporation of unnatural amino acids |
CA2500653A1 (en) | 2002-10-16 | 2004-04-29 | The Scripps Research Institute | Glycoprotein synthesis |
JP5642916B2 (ja) * | 2003-04-17 | 2014-12-17 | ザ スクリプス リサーチ インスティテュート | 真核遺伝コードの拡張 |
US7993872B2 (en) | 2003-06-18 | 2011-08-09 | The Scripps Research Institute | Unnatural reactive amino acid genetic code additions |
BRPI0412272A (pt) | 2003-07-07 | 2006-09-05 | Scripps Research Inst | composições de pares de lisil-trna e aminoacil-trna sintetase ortogonais e usos destes |
WO2005007624A2 (en) | 2003-07-07 | 2005-01-27 | The Scripps Research Institute | Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof |
EP1687401B1 (en) | 2003-10-14 | 2012-11-21 | The Scripps Research Institute | Site-specific incorporation of redox active amino acids into proteins |
WO2005074650A2 (en) | 2004-02-02 | 2005-08-18 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
US7399619B2 (en) * | 2004-05-25 | 2008-07-15 | The Scripps Research Institute | Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination |
AU2005265163B2 (en) | 2004-06-18 | 2009-10-01 | Ambrx, Inc. | Novel antigen-binding polypeptides and their uses |
US7638299B2 (en) * | 2004-07-21 | 2009-12-29 | Ambrx, Inc. | Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
ES2519444T3 (es) | 2004-09-21 | 2014-11-07 | The Scripps Research Institute | Incorporación in vivo de alquinil aminoácidos a proteínas en eubacterias |
US20080171317A1 (en) * | 2004-09-22 | 2008-07-17 | The Scripps Research Institute | Site-Specific Labeling of Proteins for Nmr Studies |
JP2008516637A (ja) | 2004-10-20 | 2008-05-22 | ザ スクリップス リサーチ インスティテュート | 真正細菌へのn−アセチルガラクトサミンアミノ酸のインビボ部位特異的組込み |
AU2005330514B2 (en) * | 2004-10-27 | 2011-05-12 | The Scripps Research Institute | Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
US7816320B2 (en) | 2004-12-22 | 2010-10-19 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 |
MX2007007590A (es) | 2004-12-22 | 2007-12-10 | Ambrx Inc | Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos. |
BRPI0518661A2 (pt) | 2004-12-22 | 2008-12-02 | Ambrx Inc | mÉtodos para expressço e purificaÇço do hormânio do crescimento humano recombinante |
BRPI0519430A2 (pt) | 2004-12-22 | 2009-02-10 | Ambrx Inc | hormânio do crescimento humano modificado |
CN101087875B (zh) | 2004-12-22 | 2012-08-22 | Ambrx公司 | 氨酰基-tRNA合成酶的组合物及其用途 |
KR20080026135A (ko) | 2005-06-03 | 2008-03-24 | 암브룩스, 인코포레이티드 | 개선된 인간 인터페론 분자 및 이의 용도 |
US20090306023A1 (en) * | 2005-06-29 | 2009-12-10 | Ramirez Jose E | Stable organic peroxide compositions |
US8586340B2 (en) | 2005-10-12 | 2013-11-19 | The Scripps Research Institute | Selective posttranslational modification of phage-displayed polypeptides |
EP2339014B1 (en) | 2005-11-16 | 2015-05-27 | Ambrx, Inc. | Methods and compositions comprising non-natural amino acids |
AU2006326404B2 (en) | 2005-12-14 | 2011-11-03 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
US7776535B2 (en) * | 2006-02-06 | 2010-08-17 | Franklin And Marshall College | Site-specific incorporation of fluorinated amino acids into proteins |
US8198044B2 (en) | 2006-03-09 | 2012-06-12 | The Scripps Research Institute | Systems for the expression of orthogonal translation components eubacterial host cells |
US8217145B2 (en) | 2006-03-16 | 2012-07-10 | The Scrips Research Institute | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
US7807411B2 (en) * | 2006-05-23 | 2010-10-05 | The Scripps Research Institute | Genetically encoded fluorescent coumarin amino acids |
KR20090060294A (ko) | 2006-09-08 | 2009-06-11 | 암브룩스, 인코포레이티드 | 변형된 인간 혈장 폴리펩티드 또는 Fc 스캐폴드 및 그의 용도 |
MX2009002526A (es) | 2006-09-08 | 2009-04-16 | Ambrx Inc | Transcripcion de tarn supresor en celulas de vertebrados. |
KR20090051227A (ko) * | 2006-09-08 | 2009-05-21 | 암브룩스, 인코포레이티드 | 척추동물 세포를 위한 하이브리드 서프레서 tRNA |
PT2052083E (pt) | 2006-09-21 | 2014-04-10 | Scripps Research Inst | Expressão geneticamente programada de proteínas seletivamente sulfatadas em eubactérias |
US20100055725A1 (en) * | 2006-10-17 | 2010-03-04 | Zymera, Inc. | System for assays of aminotransferase |
AU2007333010A1 (en) | 2006-10-18 | 2008-06-19 | The Scripps Research Institute | Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
GB0623974D0 (en) * | 2006-11-30 | 2007-01-10 | Medical Res Council | Evolved orthogonal ribosomes |
BRPI0809583B1 (pt) | 2007-03-30 | 2022-02-22 | Ambrx, Inc | Polipeptídeo fgf-21 modificado, composição compreendendo o mesmo, método para produzir o referido polipetídeo fgf-21 e célula compreendendo um polinucleotídeo |
BRPI0810622A2 (pt) | 2007-05-02 | 2020-10-13 | Ambrx, Inc. | polipeptídeos de interferon beta modificados e seus usos |
CN101918026B (zh) | 2007-11-20 | 2016-03-02 | Ambrx公司 | 经修饰胰岛素多肽和其用途 |
JP5702150B2 (ja) | 2008-02-08 | 2015-04-15 | アンブルックス, インコーポレイテッドAmbrx, Inc. | 修飾されているレプチンポリペプチドおよびそれらの使用 |
UA103774C2 (uk) | 2008-07-23 | 2013-11-25 | Амбркс, Інк. | Модифіковані поліпептиди бичачого гранулоцитарного колонієстимулювального фактора (g-csf) та їх застосування |
MX343802B (es) | 2008-09-26 | 2016-11-23 | Ambrx Inc | Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales. |
CN107022020A (zh) | 2008-09-26 | 2017-08-08 | Ambrx公司 | 修饰的动物促红细胞生成素多肽和其用途 |
WO2011073738A1 (en) | 2009-12-14 | 2011-06-23 | Metabolic Explorer | Use of inducible promoters in the production of methionine |
EA201290541A1 (ru) | 2009-12-21 | 2013-05-30 | Амбркс, Инк. | Модифицированные бычьи соматотропиновые полипептиды и их применение |
CN104017063A (zh) | 2009-12-21 | 2014-09-03 | Ambrx公司 | 经过修饰的猪促生长素多肽和其用途 |
MA34521B1 (fr) | 2010-08-17 | 2013-09-02 | Ambrx Inc | Polypeptides de relaxine modifiés et leurs utilisations |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
CN102888387B (zh) * | 2011-07-21 | 2015-03-18 | 中国科学院生物物理研究所 | 3-氯代酪氨酸翻译系统及其应用 |
JO3564B1 (ar) | 2013-03-08 | 2020-07-05 | Novartis Ag | ببتيدات وتركيبات لعلاج ضرر المفاصل |
DK2970424T3 (en) * | 2013-03-13 | 2017-07-31 | Lilly Co Eli | Modified leptide polypeptides in dogs |
EP3021942A4 (en) | 2013-07-19 | 2017-04-19 | The Regents of The University of California | Milk fat globule epidermal growth factor 8 regulates fatty acid uptake |
WO2015031268A1 (en) | 2013-08-26 | 2015-03-05 | Arizona Board Of Regents On Behalf Of Arizona State University | High affinity synbodies for influenza |
WO2016004024A1 (en) | 2014-07-02 | 2016-01-07 | Sutro Biopharma, Inc. | High growth capacity auxotrophic escherichia coli and methods of use |
CN114805533A (zh) | 2014-10-24 | 2022-07-29 | 百时美施贵宝公司 | 修饰的fgf-21多肽及其用途 |
WO2016090157A1 (en) | 2014-12-04 | 2016-06-09 | Celgene Corporation | Biomolecule conjugates |
US9744624B2 (en) * | 2015-06-17 | 2017-08-29 | Kinsus Interconnect Technology Corp. | Method for manufacturing circuit board |
JP2020500020A (ja) | 2016-11-14 | 2020-01-09 | ノバルティス アーゲー | 融合誘導性タンパク質minionに関連する組成物、方法、および治療上の使用 |
AU2017357785A1 (en) | 2016-11-14 | 2019-04-11 | Novartis Ag | Methods and compositions for treatment of cartilage damage and arthritis |
TW201837051A (zh) | 2017-02-08 | 2018-10-16 | 美商必治妥美雅史谷比公司 | 包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途 |
WO2024077277A1 (en) | 2022-10-07 | 2024-04-11 | Ambrx, Inc. | Drug linkers and antibody conjugates thereof |
WO2024091824A1 (en) | 2022-10-26 | 2024-05-02 | Ada Forsyth Institute, Inc. | Differentiation and reprogramming of chondrocyte |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990008000A (ko) | 1995-04-24 | 1999-01-25 | 로버트 에스. 화이트 헤드 | 새로운 대사 경로를 만들고 이를 스크리닝하는 방법 |
US5958672A (en) | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
US5756316A (en) | 1995-11-02 | 1998-05-26 | Genencor International, Inc. | Molecular cloning by multimerization of plasmids |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US5783431A (en) | 1996-04-24 | 1998-07-21 | Chromaxome Corporation | Methods for generating and screening novel metabolic pathways |
WO2002085923A2 (en) * | 2001-04-19 | 2002-10-31 | The Scripps Research Institute | In vivo incorporation of unnatural amino acids |
CA2500653A1 (en) * | 2002-10-16 | 2004-04-29 | The Scripps Research Institute | Glycoprotein synthesis |
-
2003
- 2003-10-15 DK DK03809019T patent/DK1578949T3/da active
- 2003-10-15 PT PT03809019T patent/PT1578949E/pt unknown
- 2003-10-15 AU AU2003277373A patent/AU2003277373B2/en not_active Expired
- 2003-10-15 CA CA2502029A patent/CA2502029C/en not_active Expired - Lifetime
- 2003-10-15 KR KR1020057006592A patent/KR20050072441A/ko active Search and Examination
- 2003-10-15 EP EP03809019A patent/EP1578949B1/en not_active Expired - Lifetime
- 2003-10-15 AT AT09003609T patent/ATE526414T1/de not_active IP Right Cessation
- 2003-10-15 US US10/530,421 patent/US7432092B2/en not_active Expired - Lifetime
- 2003-10-15 ES ES03809019T patent/ES2324608T3/es not_active Expired - Lifetime
- 2003-10-15 EP EP09003609A patent/EP2062976B1/en not_active Expired - Lifetime
- 2003-10-15 JP JP2004545280A patent/JP4444113B2/ja not_active Expired - Lifetime
- 2003-10-15 SI SI200331612T patent/SI1578949T1/sl unknown
- 2003-10-15 AT AT03809019T patent/ATE429500T1/de active
- 2003-10-15 DE DE60327369T patent/DE60327369D1/de not_active Expired - Lifetime
- 2003-10-15 MX MXPA05003983A patent/MXPA05003983A/es active IP Right Grant
- 2003-10-15 WO PCT/US2003/032576 patent/WO2004035743A2/en active Application Filing
-
2005
- 2005-03-29 IL IL167715A patent/IL167715A/en unknown
-
2006
- 2006-03-13 HK HK06103216.6A patent/HK1083351A1/xx not_active IP Right Cessation
-
2007
- 2007-10-26 US US11/978,140 patent/US8114629B2/en not_active Expired - Lifetime
- 2007-10-26 US US11/978,160 patent/US7524647B2/en not_active Expired - Lifetime
- 2007-10-26 US US11/978,182 patent/US8071344B2/en not_active Expired - Lifetime
-
2008
- 2008-08-07 US US12/228,146 patent/US7910345B2/en not_active Expired - Lifetime
-
2009
- 2009-06-24 CY CY20091100664T patent/CY1110483T1/el unknown
- 2009-07-30 AU AU2009203098A patent/AU2009203098B2/en not_active Expired
- 2009-09-29 IL IL201208A patent/IL201208A/en active IP Right Grant
-
2010
- 2010-12-29 IL IL210359A patent/IL210359A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL210359A0 (en) | Site specific incorporation of keto amino acids into proteins | |
WO2005038002A3 (en) | Site-specific incorporation of redox active amino acids into proteins | |
WO2002086075A3 (en) | Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs | |
WO2005007870A3 (en) | COMPOSITIONS OF ORTHOGONAL LEUCYL-tRNA AND AMINOACYL-tRNA SYNTHETASE PAIRS AND USES THEREOF | |
WO2005007624A3 (en) | Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof | |
SI1666604T1 (sl) | Sestavki ortogonalnih parov lizil-tRNA in aminoacil-tRNA in aminoacil-tRNA-sintetaze in njihove uporabe | |
WO2006068802A3 (en) | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF | |
WO2006034410A3 (en) | Adding photoregulated amino acids to the genetic code | |
WO2006034332A3 (en) | In vivo incorporation of alkynyl amino acids into proteins in eubacteria | |
WO2008030612A3 (en) | Site specific incorporation of non-natural amino acids by vertebrate cells | |
HK1087432A1 (en) | Expanding the eukaryotic genetic code | |
IL151940A0 (en) | HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS | |
BRPI0411475A (pt) | adições de código genético de aminoácido reativo não natural | |
IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
WO2009049223A3 (en) | Methods and compositions for the site-selective incorporation of fluorinated amino acids into polypeptides |